[3H]JNJ-54232334

N/A

Report date: 2026/01/09 17:59:29

Base Information

Drug Name[3H]JNJ-54232334
Drug Alias Name[3H]JNJ-54232334
ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Nuclides > Hydrogen > 3H
Mechanisms of ActionP2X purinoceptor 7 antagonistsRadionuclide imaging enhancers
TargetsP2X purinoceptor 7
Therapy Area/IndicationsNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesJanssen Research & Development Llc
China Registration ClassN/A

Develop Information

Active CompaniesJanssen Research & Development Llc
Inactive CompaniesN/A
Active IndicationsNervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A